BIAL appoints Joerg Holenz as R&D General Manager
BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after over 25 years leading the company’s R&D programmes.
António Portela, CEO of BIAL said: “Joerg Holenz has a proven track record of building and leading R&D organisations. We are confident he is the right person to help us scale up our R&D projects and to strengthen the company, allowing us to continue developing innovative medicines and, above all, to contribute to our mission of improving the quality of life of people around the world.”
BIAL is an innovative international pharmaceutical company committed to improving human health and quality of life for people across the globe.
Sanofi has announced it will cull its executive committee under plans orchestrated by new Chief …
The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr Richard Torbett as its …